Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis.
Saved in:
| Title: | Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis. |
|---|---|
| Authors: | Burmester G; Charité - Universitätsmedizin Berlin, Berlin, Germany., Trefler J; REUMA RESEARCH, Warsaw, Poland., Racewicz A; Zdrowie Osteo-Medic, Białystok, Poland., Jaworski J; Klinika Reuma Park, Warsaw, Poland., Zielińska A; MICS Centrum Medyczne, Warsaw, Poland., Krogulec M; NZOZ Lecznica Mak-Med, Nadarzyn, Poland., Jeka S; MICS Centrum Medyczne Toruń, CM UMK, Toruń, Poland., Wojciechowski R; Clinic and Department of Rheumatology and Systemic Diseases of Connective Tissue, University Hospital No. 2, Bydgoszcz, Poland., Kolossa K; MICS Centrum Medyczne, Bydgoszcz, Poland., Dudek A; Centrum Medyczne Amed, Warsaw, Poland., Krajewska-Włodarczyk M; Clinic of Rheumatology, School of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland., Hrycaj P; Department of Rheumatology, Municipal Hospital, Kościan, Poland., Klimiuk PA; Department of Rheumatology and Internal Diseases, Medical University of Bialystok and Inter Clinic Piotr Adrian Klimiuk, Białystok, Poland., Kim S; Celltrion, Inc., Incheon, Republic of Korea., Suh J; Celltrion, Inc., Incheon, Republic of Korea., Yang G; Celltrion, Inc., Incheon, Republic of Korea., Kim Y; Celltrion, Inc., Incheon, Republic of Korea., Jung Y; Celltrion, Inc., Incheon, Republic of Korea., Park G; Celltrion, Inc., Incheon, Republic of Korea., Smolen JS; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. josef.smolen@meduniwien.ac.at. |
| Source: | Clinical drug investigation [Clin Drug Investig] 2025 Aug; Vol. 45 (8), pp. 551-563. Date of Electronic Publication: 2025 Jul 12. |
| Publication Type: | Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Comparative Study |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
